ON

onesano S.A.

ONO · WAR · Basic Materials / Chemicals

0.712PLN+0.00 (+0.28%)

Price History

Full chart

Market Stats

Previous Close0.71
Open0.712
Day Range0.71 – 0.714
52-Week Range0.50 – 0.94
Volume5.26K
Market Cap56.39M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.07
Dividend Yield0.00%
Beta0.35
50-Day Avg0.6694
200-Day Avg0.6722

About

onesano S.A. engages in the production of products related to nutritional cycle, from agricultural production, through animal breeding, to dietetics and human supplementation in Poland. The company offers omega-3, 6, and 9 fatty acids; postbiotic Yarrowia lipolytica Novel Food, solutions in animal nutrition and dietetics; solutions in the field of bioremediation for hydrocarbon-contaminated soil based on the unique postbiotic Yarrowia lipolytica; veterinary products. It also provides dietary supplements and nutraceuticals under the EstroVita and PostVital brands; veterinary products under the Equinox and Canifelox brands; fortified foods and feed products; and natural agricultural products, as well as the production of contract brands and food raw materials. It sells its products through chain pharmacies, pharmaceutical wholesalers, drugstores, and develops sales through e-commerce platforms. The company was formerly known as Skotan SA and changed its name to onesano S.A. in March 2023. onesano S.A. was incorporated in 2001 and is headquartered in Chorzów, Poland.

Company Details

  • SectorBasic Materials
  • IndustryChemicals
  • CEOMs. Dominika Kowalczyk
  • Employees42
  • Headquartersul. Dyrekcyjna 6, Chorzów, Poland, 41-506, Poland
  • Websitehttps://onesano.pl

Leadership

  • Ms. Dominika KowalczykPresident of the Management Board
  • Piotr KrzakOperations Manager
  • Wioletta SyposzChief Accountant
  • Slawomir PaluchHead of Production & Technical Department
  • Karolina LapsaHead of Laboratory and Quality Control Department & Quality Management Department Coordinator

Financials

Income Statement

Currency: PLN2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.29M3.19M3.50M4.44M10.44M11.46M12.12M12.17M10.69M11.93M
Growth (%)-+147.25%+9.79%+26.98%+135.07%+9.72%+5.80%+0.40%-12.15%+11.58%
Cost of Revenue603.00K1.84M2.14M1.89M6.16M3.62M6.01M7.22M6.04M7.36M
Gross Profit686.00K1.34M1.36M2.56M4.29M7.84M6.11M4.95M4.65M4.57M
Gross Margin53.22%42.11%38.84%57.53%41.05%68.44%50.40%40.64%43.52%38.28%
Operating Expense8.37M4.81M6.42M6.08M4.17M9.02M9.21M11.67M10.82M8.66M
Operating Income-7.68M-3.47M-5.06M-3.52M112.00K-1.17M-3.10M-6.72M-6.17M-4.10M
Operating Margin-595.81%-108.91%-144.73%-79.23%1.07%-10.24%-25.59%-55.21%-57.65%-34.33%
EBITDA-6.70M-2.92M-3.34M-2.12M891.00K-210.00K-2.38M-5.71M-4.93M-3.64M
EBITDA Margin-519.78%-91.50%-95.46%-47.63%8.53%-1.83%-19.67%-46.90%-46.10%-30.51%
Net Income-8.10M-4.14M-4.64M-3.59M-72.00K-1.21M-3.93M-6.36M-5.80M-4.79M
Net Income Margin-628.01%-130.00%-132.61%-80.87%-0.69%-10.53%-32.41%-52.27%-54.21%-40.17%
R&D-------5.00K--
R&D as % of Total Revenue-------0.04%--
Interest Expense680.00K490.00K656.00K783.00K663.00K1.26M1.38M320.00K234.00K299.00K
Interest Expense % of Total Revenue52.75%15.37%18.75%17.62%6.35%11.01%11.35%2.63%2.19%2.51%

Balance Sheet

Currency: PLN2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets7.78M7.39M6.87M4.51M4.58M5.74M25.73M19.74M12.84M9.26M
Total Liabilities7.09M10.84M14.96M16.20M16.34M18.87M3.92M4.28M3.18M4.40M
Total Equity689.00K-3.46M-8.10M-11.69M-11.76M-13.13M21.82M15.46M9.66M4.87M
Cash236.00K627.00K134.00K269.00K329.00K59.00K19.03M10.35M3.37M314.00K
Total Debt-8.44M13.08M14.41M15.07M15.25M103.00K585.00K297.00K2.60M
Net Debt-236.00K7.81M12.94M14.14M14.74M15.19M-18.93M-9.77M-3.07M2.28M

Cash Flow

Currency: PLN2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-5.68M-3.87M-4.68M-3.29M-839.00K-453.00K-4.77M-7.68M-6.29M-3.62M
Investing Cash Flow1.07M-58.00K-18.00K2.12M402.00K236.00K-114.00K-738.00K-527.00K325.00K
Financing Cash Flow4.49M4.31M4.20M1.31M562.00K-53.00K23.85M-259.00K-169.00K244.00K
Capital Expenditure50.00K58.00K22.00K104.00K77.00K44.00K115.00K738.00K551.00K170.00K
Free Cash Flow-5.73M-3.92M-4.70M-3.40M-916.00K-497.00K-4.89M-8.42M-6.84M-3.79M
FCF to OCF100.88%101.50%100.47%103.16%109.18%109.71%102.41%109.61%108.76%104.69%

Earnings

Report DateSep 30, 2003Dec 31, 2003Sep 30, 2004Dec 31, 2004Jun 30, 2006Dec 31, 2006Mar 31, 2007Jun 30, 2007Sep 30, 2007Dec 31, 2007Mar 31, 2008Jun 30, 2008Sep 30, 2008Dec 31, 2008Mar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate------------------------------------------------------------------------------------
EPS Actual0.050.04-0.11-0.022.040.981.14-2.20-1.031.27-0.26-1.120.25-0.47-0.480.020.40-0.240.14-0.080.26-0.04-0.120.22-0.61-0.270.26-0.23-0.03-0.20-0.140.080.050.02-0.11-0.24-0.08-0.08-0.09-0.10-0.09-0.17-0.03-0.09-0.03-0.06-0.03-0.02-0.03-0.02-0.04-0.01-0.03-0.05-0.030.01-0.04-0.030.00-0.01-0.010.020.01-0.02-0.02-0.00-0.04-0.05-0.04-0.01-0.02-0.02-0.03-0.03-0.02-0.02-0.02-0.02-0.02-0.01-0.02-0.02-0.01-0.02
Surprise------------------------------------------------------------------------------------
Timing------------------------------------------------------------------------------------

Key Statistics & Ratios

Market Cap56.39M
Enterprise Value60.40M
Trailing P/E0.00
Forward P/E0.00
Price / Sales4.25
Price / Book19.77
EPS-0.07
Book Value0.046
Revenue (TTM)13.27M
Gross Profit (TTM)4.35M
EBITDA-4.29M
Profit Margin-34.19%
Operating Margin-36.41%
Return on Equity-86.14%
Return on Assets-30.42%
Shares Outstanding65.88M
Shares Float32.24M
Beta0.35
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Dec 28, 20181:2
  • Dec 20, 20003:1